首页 | 本学科首页   官方微博 | 高级检索  
检索        

免疫毒素CCL25-PE38抗急性T淋巴细胞白血病实验研究
引用本文:刘晓蕾,高磊,崔娜.免疫毒素CCL25-PE38抗急性T淋巴细胞白血病实验研究[J].中国现代医学杂志,2016,26(20):6-11.
作者姓名:刘晓蕾  高磊  崔娜
作者单位:河北省保定市第一中心医院 1.血液内科,2.彩超室,3.妇科,河北 保定 071000
摘    要:

目的  探讨免疫毒素CCL25-PE38对急性T淋巴细胞白血病(T-ALL)细胞系MOLT4(天然高水平表达CCR9)的杀伤作用,以期为T-ALL的靶向治疗提供基础。方法  通过流式细胞术、共聚焦显微术检测CCL25-PE38与MOLT4 细胞的结合及内化,Transwell趋化小室检测其趋化能力,细胞增殖试剂WST-1检测其细胞杀伤能力,Annexin V-FITC/PI染色检测其凋亡诱导效应,建立SCID小鼠白血病细胞异种移植肿瘤(CCR9+肿瘤)模型检测CCL25-PE38的抑瘤效果。结果  WST-1检测结果显示 CCL25-PE38 能特异性杀伤MOLT4细胞;Annexin V-FITC/PI染色显示CCL25-PE38主要通过凋亡诱导效应引起MOLT4细胞死亡;在SCID小鼠白血病细胞异种移植瘤模型中,注入CCL25-PE38能缓解CCR9+肿瘤的生长。结论  CCL25-PE38通过凋亡诱导作用引起MOLT4细胞死亡,缓解异种移植CCR9+肿瘤的生长。



关 键 词:

CCL25-PE38  急性T淋巴细胞白血病  免疫毒素

收稿时间:2016/2/18 0:00:00

Study of CCL25-PE38 immunotoxin in treatment of T-cell acute lymphoblastic leukemia (T-ALL)
Xiao-lei Liu,Lei Gao,Na Cui.Study of CCL25-PE38 immunotoxin in treatment of T-cell acute lymphoblastic leukemia (T-ALL)[J].China Journal of Modern Medicine,2016,26(20):6-11.
Authors:Xiao-lei Liu  Lei Gao  Na Cui
Institution:1. Department of Hematology, Baoding First Central Hospital, Baoding, Hebei 071000, China; 2. Ultrasound Department, Baoding First Central Hospital, Baoding, Hebei 071000, China; 3. Gynecology, Baoding First Central Hospital, Baoding, Hebei 071000, China
Abstract:

Objective To investigate the killing effect of CCL25-PE38 immunotoxin on MOLT4 cell line in T-cell acute lymphoblastic leukemia (T-ALL) (CCR9 natural high-level expression), and to provide the foundation of targeting treatment of T-cell acute lymphoblastic leukemia (T-ALL). Methods Flow cytometryn and confocal microscopy were used to detect the binding and internalization of CCL25-PE38 and MOLT4 cells. Transwell chemotaxis chamber method was used to detect the chemotaxis. Cell Proliferation Reagent WST and Annexin V-FITC/PI stain were used to detect killing ability of cells and the apoptosis induced effect respectively. And antitumous effect of CCI25-PE38 was detected by building the SCID leukemia cells in mice xenograft tumor (CCR9+ tumors) model. Results WST-1 test showed that CCL25-PE38 produce specific lethal effect on MOLT4 cell. Annexin V-FITC/PI stain showed that the cause of death of MOLT4 cells was induced by apoptosis of CCL25-PE38. Injection of CCL25-PE38 in SCID leukemia cells in mice xenograft tumor (CCR9+ tumors) model can retard growth speed of CCR9+ cancer. Conclusions The cause of death of MOLT4 is induced by apoptosis-inducing effect of CCL25-PE38, which can retard the growth of CCR9+ xenotransplanted tumors.

Keywords:

CCL25-PE38  T-cell acute lymphoblastic leukemia (T-ALL)  immunotoxin

点击此处可从《中国现代医学杂志》浏览原始摘要信息
点击此处可从《中国现代医学杂志》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号